|
|
Title | Creator | Relation Is Part Of |
126 |
|
Functional Connectivity in Patients with Clinically Isolated Optic Neuritis | Gregory P. Van Stavern; Beau Ances; Gregory Wu; Mae Gordon; Julie Huecker | NANOS 2013: Platform Presentations (Session II) |
127 |
|
Fusion Influences the Bielschowsky Head Tilt Test in Superior Oblique Paresis | Kristina Irsch; Howard S. Ying; David L. Guyton | NANOS 2013: Platform Presentations (Session II) |
128 |
|
Fusion Influences the Bielschowsky Head Tilt Test in Superior Oblique Paresis | Kristina Irsch; Howard S. Ying; David L. Guyton | NANOS 2013: Platform Presentations (Session II) |
129 |
|
The Ganglion Cell Layer Across the Vertical Meridian in Hemianopsia: I Get No Respect! | Kimberly M. Winges; Brennan L. Gantner; Randy H. Kardon | NANOS 2013: Platform Presentations (Session II) |
130 |
|
The Ganglion Cell Layer Across the Vertical Meridian in Hemianopsia: I Get No Respect! | Kimberly M. Winges; Brennan L. Gantner; Randy H. Kardon | NANOS 2013: Platform Presentations (Session II) |
131 |
|
Ganglion Cell Layer and Retinal Nerve Fiber Layer Analyses are Both Predictive of Visual Field Recovery Following Resection of Pituitary Adenomas | John J. Chen; Randy H. Kardon; Matthew J. Thurtell | NANOS 2013: Poster Presentations |
132 |
|
Granulomatous Hypophysitis Masquerading as Hemorrhagic Pituitary Adenoma | Ajay B. Shalwala; Hiliary H. Nickols; Louise A. Mawn | NANOS 2013: Poster Presentations |
133 |
|
Graves' Ophthalmopathy Following HTLV-I Infection | Susan C. Benes | |
134 |
|
Gravity Inversion and Anterior Ischemic Optic Neuropathy | Hana Leiba, MD; A. Kesler, MD; Y. Goldhammer, MD | |
135 |
|
Habituation-Like Response in the Striate Cortext During Functional MRI Activation | Robert M. McFadzean; B. Condon; D.M. Hadley; M.S. Bradnam; U. Shahani | |
136 |
|
Hand-Held Optical Coherence Tomography During Sedation Detects Visual Acuity and Visual Field Loss in Young Children with Optic Pathway Gliomas | Robert A. Avery; Eugene I. Hwang; Ishikawa Hiroshi; Maria T. Acosta; Kelly A. Hutcheson; Domiciano Santos; Dina J. Zand; Lindsay B. Kilburn; Kenneth N. Rosenbaum; Brian R. Rood; Joel S. Schuman; Roger J. Packer | NANOS 2013: Platform Presentations (Session II) |
137 |
|
Hand-Held Optical Coherence Tomography During Sedation Detects Visual Acuity and Visual Field Loss in Young Children with Optic Pathway Gliomas | Robert A. Avery; Eugene I. Hwang; Ishikawa Hiroshi; Maria T. Acosta; Kelly A. Hutcheson; Domiciano Santos; Dina J. Zand; Lindsay B. Kilburn; Kenneth N. Rosenbaum; Brian R. Rood; Joel S. Schuman; Roger J. Packer | NANOS 2013: Platform Presentations (Session II) |
138 |
|
Headache Management in IIH | Deborah I. Friedman, MD, MPH | NANOS 2013: Update on the Management of Idiopathic Intracranial Hypertension |
139 |
|
Headache Management in IIH | Deborah I. Friedman, MD, MPH | NANOS 2013: Update on the Management of Idiopathic Intracranial Hypertension |
140 |
|
Homocystinuria and Stroke | Aki Kawasaki | |
141 |
|
Homonymous Hemianopia with a Normal MRI: When to Consider Retinal Mimics of Neurologic Disease | Aimee J. Szewka | NANOS 2013: Poster Presentations |
142 |
|
Homonymous Horizontal Sectoranopia and the Central Field | Satoshi Kashii | |
143 |
|
Horizons in Neurosurgery: Skull Base Surgery | Linda Sternau, MD | |
144 |
|
Horizontal Gaze Palsy with Progressive Scoliosis and Characteristic MRI Appearance | Lora R. Dagi Glass; Jeffrey G. Odel; Angela Lignelli | NANOS 2013: Poster Presentations |
145 |
|
How to Best Measure Afferent Visual Pathway Damage in Neuro-Ophthalmic Disorders - The Optic Nerve, Reintal Nerve Fiber Layer, and Beyond! | Fiona Costello, MD, FRCP | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
146 |
|
How to Best Measure Afferent Visual Pathway Damage in Neuro-Ophthalmic Disorders - The Optic Nerve, Reintal Nerve Fiber Layer, and Beyond! | Fiona Costello, MD, FRCP | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
147 |
|
How to Capture Disease Activity in the Longitudinal Follow-Up of Optic Neuropathies? | Eric Eggenberger, DO, MSEpi | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
148 |
|
How to Capture Disease Activity in the Longitudinal Follow-Up of Optic Neuropathies? | Eric Eggenberger, DO, MSEpi | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
149 |
|
How to Distinguish Pseudopapilledema from Papilledema | Anthony Arnold | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
150 |
|
How to Distinguish Pseudopapilledema from Papilledema | Anthony Arnold | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |